Use of the cholesterol lowering drugs Lipitor, Zocor or Crestor may increase the risk of a woman's chance of developing Type-2 diabetes. Lipitor, Zocor and Crestor are known as statins.
According to the FDA, Lipitor, Zocor and Crestor are intended to help lower a person’s “bad” cholesterol.
The Food and Drug Administration (FDA) approved a warning label change for Lipitor, Zocor and Crestor, to include a risk of type 2 diabetes. The FDA cholesterol-lowing drug label changes warn of an increase in blood sugar levels (hyperglycemia) with statin use. The FDA is also aware of studies showing statin receipients may have an increased risk of increased blood sugar levels and of being diagnosed with type 2 diabetes. The labels will now warn healthcare professionals and patients of this potential risk.
According to the FDA, diabetes occurs because of defects in the body’s ability to produce or use insulin—a hormone needed to convert food into energy. If the pancreas doesn't make enough insulin or if cells do not respond appropriately to insulin, blood sugar levels in the blood get too high, which can lead to serious health problems.
An increased risk of raised blood sugar levels and the development of Type 2 diabetes have been reported with the use of Lipitor, Zocor and Crestor.
Please feel free to contact a LIpitor, Zocor or Crestor attorney using the form to the right or by dialing 1-800-888-4425. One of our experienced attorneys will help evaluate your claim and explain your legal rights for free. All information is kept private.
Web Development by Creative Arc, a Minneapolis Web Design firm.